Docoh
Loading...

APM Aptorum

Aptorum Group Limited  is a pharmaceutical company dedicated to the discovery, development and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers (including orphan oncology indications). The pipeline of Aptorum is also enriched through the establishment of drug discovery platforms that enable the discovery of new therapeutics assets through programs such as the systematic screening of existing approved drug molecules and microbiome-based research platform for treatments of metabolic diseases. Aptorum also has projects focused on microbiome research and the commercialization of a natural supplement product targeted for women undergoing menopause and experiencing related symptoms.

APM stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

19 Apr 21
24 Oct 21
31 Dec 21
Quarter (USD)
Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Aptorum earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 13 9 +44.4%
Opened positions 6 9 -33.3%
Closed positions 2 1 +100.0%
Increased positions 2 0 NEW
Reduced positions 2 0 NEW
13F shares
Current Prev Q Change
Total value 456.81M 600K +76035.3%
Total shares 165.42M 201.43K +82023.8%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Huen Ian Chung Yuen 164.86M $455.01M NEW
Geode Capital Management 301.22K $962K +1690.1%
Redmond Asset Management 59.24K $189K 0.0%
Jane Street 53.62K $171K NEW
Renaissance Technologies 45.7K $146K NEW
Schonfeld Strategic Advisors 43.8K $140K 0.0%
Acadian Asset Management 28.99K $93K NEW
MS Morgan Stanley 13.4K $43K NEW
Citadel Advisors 10.91K $35K -80.9%
Tower Research Capital 3.84K $12K NEW
Largest transactions
Shares Bought/sold Change
Huen Ian Chung Yuen 164.86M +164.86M NEW
Geode Capital Management 301.22K +284.4K +1690.1%
Jane Street 53.62K +53.62K NEW
Citadel Advisors 10.91K -46.11K -80.9%
Renaissance Technologies 45.7K +45.7K NEW
Acadian Asset Management 28.99K +28.99K NEW
VIRT Virtu Financial 0 -19.82K EXIT
MS Morgan Stanley 13.4K +13.4K NEW
Tower Research Capital 3.84K +3.84K NEW
WFC Wells Fargo & Co. 0 -1.58K EXIT
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg

Proxies

No filings